CA2462660A1 - Proteines associees aux acides nucleiques - Google Patents
Proteines associees aux acides nucleiques Download PDFInfo
- Publication number
- CA2462660A1 CA2462660A1 CA002462660A CA2462660A CA2462660A1 CA 2462660 A1 CA2462660 A1 CA 2462660A1 CA 002462660 A CA002462660 A CA 002462660A CA 2462660 A CA2462660 A CA 2462660A CA 2462660 A1 CA2462660 A1 CA 2462660A1
- Authority
- CA
- Canada
- Prior art keywords
- seq
- polynucleotide
- polypeptide
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6875—Nucleoproteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Pain & Pain Management (AREA)
- Cell Biology (AREA)
- Neurosurgery (AREA)
- Microbiology (AREA)
- Neurology (AREA)
- Oncology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Communicable Diseases (AREA)
- General Physics & Mathematics (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
Abstract
L'invention concerne dans divers modes de réalisation des protéines humaines associées aux acides nucléiques (NAAP) et des polynucléotides identifiant et codant pour les NAAP. Des modes de réalisation de l'invention concernent également des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes et des antagonistes. D'autres modes de réalisation concernent des méthodes de diagnostic, de traitement ou de prévention des troubles associés à l'expression aberrante des NAAP.
Applications Claiming Priority (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34844201P | 2001-10-29 | 2001-10-29 | |
US60/348,442 | 2001-10-29 | ||
US33554401P | 2001-11-01 | 2001-11-01 | |
US60/335,544 | 2001-11-01 | ||
US33753501P | 2001-11-05 | 2001-11-05 | |
US60/337,535 | 2001-11-05 | ||
US34465001P | 2001-11-09 | 2001-11-09 | |
US60/344,650 | 2001-11-09 | ||
US33476201P | 2001-11-15 | 2001-11-15 | |
US60/334,762 | 2001-11-15 | ||
PCT/US2002/034846 WO2003038052A2 (fr) | 2001-10-29 | 2002-10-29 | Proteines associees aux acides nucleiques |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2462660A1 true CA2462660A1 (fr) | 2003-05-08 |
Family
ID=27541124
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002462660A Abandoned CA2462660A1 (fr) | 2001-10-29 | 2002-10-29 | Proteines associees aux acides nucleiques |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1497315A2 (fr) |
JP (1) | JP2005508636A (fr) |
AU (1) | AU2002359333A1 (fr) |
CA (1) | CA2462660A1 (fr) |
WO (1) | WO2003038052A2 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002310256A1 (en) * | 2001-06-05 | 2002-12-16 | Exelixis Inc. | Ppp2cs as modifiers of the p53 pathway and methods of use |
WO2006120019A2 (fr) * | 2005-05-13 | 2006-11-16 | Centre National De La Recherche Scientifique | Utilisation de nouveau codage genique pour nouvel element de la famille mcm2-8 dans les compositions pharmaceutiques |
WO2012040127A1 (fr) | 2010-09-22 | 2012-03-29 | Alios Biopharma, Inc. | Analogues nucléotidiques substitués |
CA2860234A1 (fr) | 2011-12-22 | 2013-06-27 | Alios Biopharma, Inc. | Analogues de nucleotide phosphorothioate substitue |
NZ631601A (en) | 2012-03-21 | 2016-06-24 | Alios Biopharma Inc | Solid forms of a thiophosphoramidate nucleotide prodrug |
NZ630805A (en) | 2012-03-22 | 2016-01-29 | Alios Biopharma Inc | Pharmaceutical combinations comprising a thionucleotide analog |
-
2002
- 2002-10-29 AU AU2002359333A patent/AU2002359333A1/en not_active Abandoned
- 2002-10-29 CA CA002462660A patent/CA2462660A1/fr not_active Abandoned
- 2002-10-29 EP EP02793861A patent/EP1497315A2/fr not_active Withdrawn
- 2002-10-29 WO PCT/US2002/034846 patent/WO2003038052A2/fr not_active Application Discontinuation
- 2002-10-29 JP JP2003540317A patent/JP2005508636A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1497315A2 (fr) | 2005-01-19 |
WO2003038052A3 (fr) | 2004-11-11 |
WO2003038052A2 (fr) | 2003-05-08 |
JP2005508636A (ja) | 2005-04-07 |
AU2002359333A1 (en) | 2003-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004087875A2 (fr) | Proteines associees a des acides nucleiques | |
WO2003094848A2 (fr) | Proteines associees a des acides nucleiques | |
CA2462660A1 (fr) | Proteines associees aux acides nucleiques | |
WO2003076586A2 (fr) | Proteines associees a des acides nucleiques | |
WO2003054219A2 (fr) | Proteines associees a des acides nucleiques | |
US20040137448A1 (en) | Nucleic acid-associated proteins | |
CA2449440A1 (fr) | Proteines structurelles et associees au cytosquelette | |
WO2003077875A2 (fr) | Proteines associees a la croissance, a la differenciation et a la mort cellulaires | |
CA2449272A1 (fr) | Molecules intracellulaires de signalisation | |
WO2003010329A2 (fr) | Proteines associees a des acides nucleiques | |
CA2463000A1 (fr) | Proteines associees aux vesicules | |
WO2004031364A2 (fr) | Proteines associees a la croissance, a la differenciation, et a la mort des cellules | |
WO2004015396A2 (fr) | Proteines d'adhesion cellulaire et de matrice extracellulaire | |
WO2002099115A2 (fr) | Proteines associees a des acides nucleiques | |
US20050118582A1 (en) | Nucleic acid-associated proteins | |
WO2003095622A2 (fr) | Proteines associees a la croissance, la differentiation et la mort cellulaires | |
WO2003094843A2 (fr) | Proteines d'adhesion cellulaire et a matrice extracellulaire | |
EP1434788A2 (fr) | Proteines associees a la croissance ,la differenciation et la mort cellulaires | |
WO2004067712A2 (fr) | Molecules de signalisation intracellulaire | |
WO2004011604A2 (fr) | Proteines associees a des acides nucleiques | |
WO2002079389A2 (fr) | Proteines associees aux acides nucleiques | |
WO2003046151A2 (fr) | Proteines associees a des acides nucleiques | |
EP1478762A2 (fr) | Proteine liees a des acide nucleiques | |
WO2002050279A2 (fr) | Proteines associees a un acide nucleique | |
EP1430130A2 (fr) | Proteines associees a des acides nucleiques |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |